Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Aebischer

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
ASAIO Transactions|July 1, 1986
Tissue developed around bioresorbable implants. Load-bearing versus histologyP D Richardson, H Sasken, A Parhizgar, et al.
NMR in Biomedicine|June 20, 2012
An in vivo ultrahigh field 14.1 T (1) H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson's disease: GABA as an early disease markerP G Coune, M Craveiro, M N Gaugler, et al.
Cell Transplantation|October 19, 2000
Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cellsA D Zurn, H Henry, M Schluep, et al.
Restorative Neurology and Neuroscience|May 10, 2011
Encapsulation of neurotrophic factor-releasing cells for the treatment of neurodegenerative diseasesP Aebischer, S A Tan, N Déglon, et al.
Experimental Neurology|November 22, 2008
Implication of the JNK pathway in a rat model of Huntington's diseaseV Perrin, N Dufour, C Raoul, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2006
Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasLC Raoul, E Buhler, C Sadeghi, et al.
Gene Therapy|April 25, 2001
Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemiaC Rinsch, P Quinodoz, B Pittet, et al.
Anesthesiology|November 1, 1996
Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experienceE Buchser, M Goddard, B Heyd, et al.
Transplantation|December 15, 1994
Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. A preliminary reportP Aebischer, E Buchser, J M Joseph, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1985
Coated bioresorbable mesh as vascular graft materialP M Galletti, L A Trudell, T H Chiu, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
ASAIO Transactions|July 1, 1986
Tissue developed around bioresorbable implants. Load-bearing versus histologyP D Richardson, H Sasken, A Parhizgar, et al.
NMR in Biomedicine|June 20, 2012
An in vivo ultrahigh field 14.1 T (1) H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson's disease: GABA as an early disease markerP G Coune, M Craveiro, M N Gaugler, et al.
Cell Transplantation|October 19, 2000
Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cellsA D Zurn, H Henry, M Schluep, et al.
Restorative Neurology and Neuroscience|May 10, 2011
Encapsulation of neurotrophic factor-releasing cells for the treatment of neurodegenerative diseasesP Aebischer, S A Tan, N Déglon, et al.
Experimental Neurology|November 22, 2008
Implication of the JNK pathway in a rat model of Huntington's diseaseV Perrin, N Dufour, C Raoul, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2006
Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasLC Raoul, E Buhler, C Sadeghi, et al.
Gene Therapy|April 25, 2001
Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemiaC Rinsch, P Quinodoz, B Pittet, et al.
Anesthesiology|November 1, 1996
Immunoisolated xenogenic chromaffin cell therapy for chronic pain. Initial clinical experienceE Buchser, M Goddard, B Heyd, et al.
Transplantation|December 15, 1994
Transplantation in humans of encapsulated xenogeneic cells without immunosuppression. A preliminary reportP Aebischer, E Buchser, J M Joseph, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1985
Coated bioresorbable mesh as vascular graft materialP M Galletti, L A Trudell, T H Chiu, et al.
Pageof 18